Annual SGA
$266.99 M
+$56.14 M+26.62%
December 31, 2021
Summary
- As of February 10, 2025, GBT annual SGA is $266.99 million, with the most recent change of +$56.14 million (+26.62%) on December 31, 2021.
- During the last 3 years, GBT annual SGA has risen by +$215.55 million (+419.08%).
Performance
GBT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly SGA
$81.09 M
+$6.55 M+8.79%
June 30, 2022
Summary
- As of February 10, 2025, GBT quarterly SGA is $81.09 million, with the most recent change of +$6.55 million (+8.79%) on June 30, 2022.
- Over the past year, GBT quarterly SGA has increased by +$20.00 million (+32.73%).
Performance
GBT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$5.32 B
-$322.46 M-6.46%
June 30, 2022
Summary
- As of February 10, 2025, GBT TTM SGA is -$5.32 billion, with the most recent change of -$322.46 million (-6.46%) on June 30, 2022.
- Over the past year, GBT TTM SGA has dropped by -$5.55 billion (-2370.10%).
Performance
GBT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
GBT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.6% | +32.7% | -2370.1% |
| 3 y3 years | +419.1% | +227.1% | -4640.1% |
| 5 y5 years | +749.3% | +1218.1% | -4640.1% |
GBT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -8.1% | +13.5% | at low |
| 5 y | 5-year | at high | -56.1% | at high | -45.0% | +114.2% | at low |
| alltime | all time | at high | -99.1% | at high | -99.2% | >+9999.0% | at low |
Global Blood Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $81.09 M(+8.8%) | $302.55 M(+7.1%) |
| Mar 2022 | - | $74.53 M(-5.6%) | $282.56 M(+5.8%) |
| Dec 2021 | $266.99 M(+26.6%) | $78.94 M(+16.1%) | $266.99 M(+7.8%) |
| Sep 2021 | - | $67.99 M(+11.3%) | $247.67 M(+5.8%) |
| Jun 2021 | - | $61.09 M(+3.6%) | $234.17 M(+5.4%) |
| Mar 2021 | - | $58.97 M(-1.1%) | $222.16 M(+5.4%) |
| Dec 2020 | $210.85 M(+80.1%) | $59.62 M(+9.4%) | $210.85 M(+7.7%) |
| Sep 2020 | - | $54.49 M(+11.0%) | $195.81 M(+14.5%) |
| Jun 2020 | - | $49.08 M(+3.0%) | $170.98 M(+16.6%) |
| Mar 2020 | - | $47.66 M(+6.9%) | $146.69 M(+25.3%) |
| Dec 2019 | $117.09 M(+127.6%) | $44.59 M(+50.4%) | $117.09 M(+33.3%) |
| Sep 2019 | - | $29.65 M(+19.6%) | $87.82 M(+24.4%) |
| Jun 2019 | - | $24.79 M(+37.3%) | $70.62 M(+24.5%) |
| Mar 2019 | - | $18.05 M(+17.9%) | $56.74 M(+10.3%) |
| Dec 2018 | $51.44 M | $15.32 M(+23.1%) | $51.44 M(+10.1%) |
| Sep 2018 | - | $12.45 M(+14.1%) | $46.74 M(+9.9%) |
| Jun 2018 | - | $10.91 M(-14.4%) | $42.51 M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $12.75 M(+20.1%) | $37.75 M(+20.1%) |
| Dec 2017 | $31.44 M(+50.0%) | $10.62 M(+29.1%) | $31.44 M(+14.9%) |
| Sep 2017 | - | $8.23 M(+33.7%) | $27.37 M(+10.0%) |
| Jun 2017 | - | $6.15 M(-4.4%) | $24.87 M(+7.7%) |
| Mar 2017 | - | $6.44 M(-1.7%) | $23.10 M(+10.2%) |
| Dec 2016 | $20.96 M(+116.8%) | $6.55 M(+14.3%) | $20.96 M(+12.6%) |
| Sep 2016 | - | $5.73 M(+30.9%) | $18.61 M(+19.7%) |
| Jun 2016 | - | $4.38 M(+1.8%) | $15.55 M(+22.7%) |
| Mar 2016 | - | $4.30 M(+2.5%) | $12.68 M(+31.1%) |
| Dec 2015 | $9.67 M(+150.9%) | $4.20 M(+57.3%) | $9.67 M(+44.1%) |
| Sep 2015 | - | $2.67 M(+77.2%) | $6.71 M(+30.3%) |
| Jun 2015 | - | $1.51 M(+16.0%) | $5.15 M(+18.9%) |
| Mar 2015 | - | $1.30 M(+4.9%) | $4.33 M(+12.4%) |
| Dec 2014 | $3.85 M(+67.0%) | $1.24 M(+11.5%) | $3.85 M(+47.2%) |
| Sep 2014 | - | $1.11 M(+61.2%) | $2.62 M(+73.5%) |
| Jun 2014 | - | $688.00 K(-16.2%) | $1.51 M(+83.8%) |
| Mar 2014 | - | $821.00 K | $821.00 K |
| Dec 2013 | $2.31 M | - | - |
FAQ
- What is Global Blood Therapeutics annual SGA?
- What is the all time high annual SGA for Global Blood Therapeutics?
- What is Global Blood Therapeutics annual SGA year-on-year change?
- What is Global Blood Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Global Blood Therapeutics?
- What is Global Blood Therapeutics quarterly SGA year-on-year change?
- What is Global Blood Therapeutics TTM SGA?
- What is the all time high TTM SGA for Global Blood Therapeutics?
- What is Global Blood Therapeutics TTM SGA year-on-year change?
What is Global Blood Therapeutics annual SGA?
The current annual SGA of GBT is $266.99 M
What is the all time high annual SGA for Global Blood Therapeutics?
Global Blood Therapeutics all-time high annual SGA is $266.99 M
What is Global Blood Therapeutics annual SGA year-on-year change?
Over the past year, GBT annual SGA has changed by +$56.14 M (+26.62%)
What is Global Blood Therapeutics quarterly SGA?
The current quarterly SGA of GBT is $81.09 M
What is the all time high quarterly SGA for Global Blood Therapeutics?
Global Blood Therapeutics all-time high quarterly SGA is $81.09 M
What is Global Blood Therapeutics quarterly SGA year-on-year change?
Over the past year, GBT quarterly SGA has changed by +$20.00 M (+32.73%)
What is Global Blood Therapeutics TTM SGA?
The current TTM SGA of GBT is -$5.32 B
What is the all time high TTM SGA for Global Blood Therapeutics?
Global Blood Therapeutics all-time high TTM SGA is -$49.33 M
What is Global Blood Therapeutics TTM SGA year-on-year change?
Over the past year, GBT TTM SGA has changed by -$5.55 B (-2370.10%)